SEC Tracker
Get the app

Kala Bio KALA

Kala Pharmaceuticals, Inc. and Combangio, Inc., a wholly-owned subsidiary of the Company

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Kala Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lexaria Bioscience LEXX public float $25M, Feb 28, 2025, over 18 months old
  2. Curis CRIS public float $25M, Jun 30, 2025
  3. Dyadic International DYAI public float $24M, Jun 30, 2025
  4. Pulmatrix PULM public float $25M, Jun 30, 2025
  5. Aytu Biopharma AYTU public float $24M, Dec 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.